Bryan Garnier - NEL (NEL.OL) NEL: Good top-line but we struggle to see further acceleration as order backlog is slightly down | SELL | NOK10 (-28%)

Report

Bryan Garnier

Xavier Regnard

NEL: Good top-line but we struggle to see further acceleration as order backlog is slightly down | SELL | NOK10 (-28%)

NEL - SELL | NOK10 (-28%)
Good top-line but we struggle to see further acceleration as order backlog is slightly down

Finally a good top-line growth…
…but second quarter in a row of decreasing order backlog
Sell rating confirmed, TP NOK10

21/10/2021 5 EN

Underlying

NEL

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Xavier Regnard

Other Reports on these Companies

Bryan Garnier

Energy transition & Sustainability Green hydrogen finally ready for take-off | HydrogenPro initiation of coverage Buy – Tprice NOK50/share

The green hydrogen market is moving from a proof-of-concept stage to commercial implementation, accompanied by strong growth in equipment sales. According to BloombergNEF (BNEF), electrolyser sales are projected to at least quadruple in 2022, from c.460 MW in 2021 to 1.8-2.5 GW in 2022, depending on the scenario HydrogenPro initiation of coverage Buy – Tprice NOK50/share Ceres Power Still one of our favourite stocks in the sector ITM Power Struggling to deliver on time McPhy Heading for new cuts in consensus estimates NEL Well positioned in the US market

September 30, 2022 September 30, 2022 1 EN

Bryan Garnier

NEL: Record order for 200 MW of alkaline electrolyser | SELL | NOK10

NEL - SELL | NOK10 Record order for 200 MW of alkaline electrolyser Nel’s largest purchase order to date Strong improvement in cost competitiveness Good news but probably no consensus upward adjustment as expectations were already ambitious

July 18, 2022 July 18, 2022 1 EN

Bryan Garnier

NEL: Top-line below expectations, challenged by supply chain disruptions | SELL | NOK10

NEL - SELL | NOK10 Top-line below expectations, challenged by supply chain disruptions Big miss on the top-line and wider than expected EBITDA loss What about FY’22 consensus expectations ? Sell rating confirmed

May 11, 2022 May 11, 2022 1 EN

Beiersdorf 2025 guidance reiterated, despite poor Q1

Beiersdorf Q1 sales were above consensus at the group level and in line for the Consumer division. More importantly, despite poor Q1 momentum, which was expected, the group's management has reiterated its 2025 guidance. We confirm our Neutral recommendation and our PT as we have made no change to o

April 16, 2025 April 16, 2025 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Waga Energy: a good FY24 performance

Although FY24 headline metrics were slightly below consensus at EUR55.7m (-6% vs cons. at EUR59.3m), Waga Energy has reported a lower-than-expected EBITDA loss of -EUR2.6m (vs cons. at -EUR6m). This was driven by operating leverage, improved gross margin and robust cost control. With 30 units in op

April 15, 2025 April 15, 2025 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Valneva: Ixchiq approved in Brazil

Valneva announced that Brazil’s ANVISA has approved Ixchiq for adults >18 y.o., making it the first chikungunya vaccine approved in an endemic country. Strategically, while we expect limited sales contributions to Valneva from Brazil (upside to our base case made of the US/EU travellers market),

April 15, 2025 April 15, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

NEL: Good top-line but we struggle to see further acceleration as order backlog is slightly down | SELL | NOK10 (-28%)

Energy transition & Sustainability Green hydrogen finally ready for take-off | HydrogenPro initiation of coverage Buy – Tprice NOK50/share

NEL: Record order for 200 MW of alkaline electrolyser | SELL | NOK10

NEL: Top-line below expectations, challenged by supply chain disruptions | SELL | NOK10

Beiersdorf 2025 guidance reiterated, despite poor Q1

Waga Energy: a good FY24 performance

Valneva: Ixchiq approved in Brazil

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe